Log In
Print this Print this

AN788 (formerly NSD-788)

  Manage Alerts
Collapse Summary General Information
Company Saniona AB
DescriptionMonoamine reuptake inhibitor
Molecular Target
Mechanism of ActionMonoamine reuptake inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I
Standard IndicationDepression
Indication DetailsTreat major depressive disorder (MDD)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today